ATE318593T1 - Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut - Google Patents

Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut

Info

Publication number: ATE318593T1
Authority: AT; Austria
Prior art keywords: tretinoin; skin; vehicle; weight percent; treated
Prior art date: 1997-05-09

Application number

AT98921064T

Other languages

English (en)

Inventor

Douglas E Kligman

Albert M Kligman

Original Assignee

Douglas E Kligman

Albert M Kligman

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-09

Filing date

1998-05-11

Publication date

2006-03-15

1998-05-11 Application filed by Douglas E Kligman, Albert M Kligman filed Critical Douglas E Kligman

2006-03-15 Application granted granted Critical

2006-03-15 Publication of ATE318593T1 publication Critical patent/ATE318593T1/de

Links

SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 abstract 6
229960001727 tretinoin Drugs 0.000 abstract 6
239000000203 mixture Substances 0.000 abstract 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
208000017520 skin disease Diseases 0.000 abstract 2
239000002904 solvent Substances 0.000 abstract 2
208000002874 Acne Vulgaris Diseases 0.000 abstract 1
206010003694 Atrophy Diseases 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
206010066295 Keratosis pilaris Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
206010051246 Photodermatosis Diseases 0.000 abstract 1
241001303601 Rosacea Species 0.000 abstract 1
206010040844 Skin exfoliation Diseases 0.000 abstract 1
206010000496 acne Diseases 0.000 abstract 1
230000037444 atrophy Effects 0.000 abstract 1
239000006071 cream Substances 0.000 abstract 1
230000035618 desquamation Effects 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
230000001804 emulsifying effect Effects 0.000 abstract 1
239000000499 gel Substances 0.000 abstract 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
230000003810 hyperpigmentation Effects 0.000 abstract 1
208000000069 hyperpigmentation Diseases 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
239000002674 ointment Substances 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1
201000004700 rosacea Diseases 0.000 abstract 1
230000037390 scarring Effects 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1
230000037303 wrinkles Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Toxicology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT98921064T 1997-05-09 1998-05-11 Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut ATE318593T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4607097P	1997-05-09	1997-05-09
US09/071,017 US6008254A (en)	1997-05-09	1998-05-01	Method of treating skin disorders with high-strength tretinoin

Publications (1)

Publication Number	Publication Date
ATE318593T1 true ATE318593T1 (de)	2006-03-15

Family

ID=26723533

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98921064T ATE318593T1 (de)	1997-05-09	1998-05-11	Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut

Country Status (8)

Country	Link
US (2)	US6008254A (de)
EP (1)	EP0980243B1 (de)
AT (1)	ATE318593T1 (de)
AU (1)	AU7374998A (de)
CA (1)	CA2288706C (de)
DE (1)	DE69833651T2 (de)
ES (1)	ES2260834T3 (de)
WO (1)	WO1998050023A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6008254A (en) *	1997-05-09	1999-12-28	Kligman; Douglas E.	Method of treating skin disorders with high-strength tretinoin
AUPP583198A0 (en) *	1998-09-11	1998-10-01	Soltec Research Pty Ltd	Mousse composition
US8263580B2 (en) *	1998-09-11	2012-09-11	Stiefel Research Australia Pty Ltd	Vitamin formulation
KR20030017502A (ko) *	2000-04-28	2003-03-03	에프. 호프만-라 로슈 아게	파라(설포닐)아릴 및 헤테로아릴
US6353029B1 (en)	2000-08-24	2002-03-05	Bristol-Myers Squibb Company	Storage stable tretinoin and 4-hydroxyanisole containing topical composition
MXPA03009995A (es)	2001-05-09	2004-06-30	Univ Michigan	Uso de composiciones para tratar rosacea.
US20050159485A1 (en) *	2002-01-04	2005-07-21	Jost-Price Edward R.	Combinations for the treatment of immunoinflammatory disorders and proliferative skin diseases
US20040097587A1 (en) *	2002-03-27	2004-05-20	Arbiser Jack L	Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
US20030203013A1 (en) *	2002-04-26	2003-10-30	Xylos Corporation	Microbial cellulose wound dressing for treating chronic wounds
US7390499B2 (en)	2002-04-26	2008-06-24	Lohmann & Rauscher Gmbh	Microbial cellulose wound dressing for treating chronic wounds
US7704523B2 (en) *	2002-04-26	2010-04-27	Lohmann & Rauscher Gmbh	Microbial cellulose wound dressing for treating chronic wounds
US20050019380A1 (en) *	2002-04-26	2005-01-27	Xylos Corporation	Microbial cellulose wound dressing for treating chronic wounds
US20080025929A1 (en) *	2004-02-19	2008-01-31	Chemaphor, Inc.	Topical Formulations for the Treatment of Skin Conditions
FR2870125B1 (fr) *	2004-05-12	2010-03-26	Dermaconcept Jmc	Formulation du type spot-on utile en cosmetologie et en dermatologie
WO2006034570A1 (en)	2004-09-28	2006-04-06	Chemaphor Inc.	Compositions and methods for promoting weight gain and feed conversion
US20060251598A1 (en) *	2004-12-02	2006-11-09	Ramirez Jose E	System for improved percutaneous absorption of skin benefiting agents
WO2006102604A2 (en) *	2005-03-24	2006-09-28	Anacor Pharmaceuticals, Inc.	Topical formulations of borinic acid antibodies and their methods of use
EP2526930B1 (de) *	2005-06-01	2013-12-25	GlaxoSmithKline Intellectual Property Development Limited	Vitaminformulierung
US20060294437A1 (en) *	2005-06-22	2006-12-28	Thunder Creative Technologies, Inc.	Point-of-load power conditioning for memory modules
US7709631B2 (en)	2006-03-13	2010-05-04	Xylos Corporation	Oxidized microbial cellulose and use thereof
US20070286884A1 (en) *	2006-06-13	2007-12-13	Xylos Corporation	Implantable microbial cellulose materials for hard tissue repair and regeneration
CA2686511A1 (fr) *	2007-05-11	2008-11-20	Galderma Research & Development	Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
EP2214656B1 (de) *	2007-10-26	2018-12-05	Avivagen Inc.	Zusammensetzungen und verfahren zur verstärkung der immunantwort
AU2010242502B2 (en)	2009-04-30	2016-11-10	Avivagen Inc.	Methods and compositions for improving the health of animals
WO2016022703A1 (en) *	2014-08-06	2016-02-11	Thesan Pharmaceuticals, Inc.	Agonists of the ahr receptor pathway having sebosuppressive activity and a method for identifying said agonists
BR112018008556A2 (pt) *	2015-10-30	2018-10-23	Patagonia Pharmaceuticals Llc	?composições farmacêuticas e métodos para tratar ictiose congênita?

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3729568A (en) *	1969-09-23	1973-04-24	Johnson & Johnson	Acne treatment
US4603146A (en) *	1984-05-16	1986-07-29	Kligman Albert M	Methods for retarding the effects of aging of the skin
US4888342A (en) *	1984-05-16	1989-12-19	Kligman Albert M	Methods for treatment of sundamaged human skin with retinoids
US5019569A (en) *	1986-11-03	1991-05-28	Ortho Pharmaceutical Corporation	Reversal of glucocorticoid-induced skin atrophy
MY106263A (en) *	1989-01-19	1995-04-29	Ortho Pharma Corp	Method for the treatment or prevention of intrinsically aged skin with retinoids
AU1585692A (en) *	1991-02-27	1992-10-06	Albert M. Kligman	Methods for treatment of scarring fibrotic alopecia
US5051449A (en) *	1991-02-27	1991-09-24	Kligman Albert M	Treatment of cellulite with retinoids
EP0625045A4 (de) *	1992-02-07	1995-01-18	Albert M Kligman	Verfahren zur behandlung von entzündlichen dermatosen.
AU670777B2 (en) *	1992-04-16	1996-08-01	Ortho Pharmaceutical Corporation	Aqueous gel vehicles for retinoids
US6008254A (en) *	1997-05-09	1999-12-28	Kligman; Douglas E.	Method of treating skin disorders with high-strength tretinoin

1998
- 1998-05-01 US US09/071,017 patent/US6008254A/en not_active Expired - Lifetime
- 1998-05-11 DE DE69833651T patent/DE69833651T2/de not_active Expired - Fee Related
- 1998-05-11 AU AU73749/98A patent/AU7374998A/en not_active Abandoned
- 1998-05-11 WO PCT/US1998/009440 patent/WO1998050023A1/en not_active Ceased
- 1998-05-11 EP EP98921064A patent/EP0980243B1/de not_active Expired - Lifetime
- 1998-05-11 AT AT98921064T patent/ATE318593T1/de not_active IP Right Cessation
- 1998-05-11 CA CA002288706A patent/CA2288706C/en not_active Expired - Fee Related
- 1998-05-11 ES ES98921064T patent/ES2260834T3/es not_active Expired - Lifetime
2000
- 2000-05-09 US US09/567,792 patent/US6228887B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE69833651D1 (de)	2006-04-27
CA2288706C (en)	2007-10-16
EP0980243A1 (de)	2000-02-23
CA2288706A1 (en)	1998-11-12
DE69833651T2 (de)	2006-12-28
WO1998050023A1 (en)	1998-11-12
EP0980243B1 (de)	2006-03-01
AU7374998A (en)	1998-11-27
ES2260834T3 (es)	2006-11-01
US6228887B1 (en)	2001-05-08
US6008254A (en)	1999-12-28

Similar Documents

Publication	Publication Date	Title
ATE318593T1 (de)	2006-03-15	Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut
Piérard-Franchimont et al.	2000	A randomized, placebo-controlled trial of topical retinol in the treatment of cellulite
Ehrlich et al.	2006	Improvement in the appearance of wrinkles with topical transforming growth factor β1 and L-ascorbic acid
RU94045258A (ru)	1996-10-20	Косметическая или дерматологическая композиция для одновременного лечения поверхностных и глубоких слоев кожи и ее применение
BR0015604A (pt)	2002-11-12	Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas
DE59410301D1 (de)	2003-07-31	Topische zubereitungen mit einem gehalt an l-arginin
BR9711671A (pt)	2000-01-18	Tratamento com ácido graxo.
ATE398995T1 (de)	2008-07-15	Hautpflegemittel die salicylsäure enthalten
NO944958D0 (no)	1994-12-21	Kosmetisk preparat, fremgangsmåte for fremstilling av dette, samt anvendelse derav
CA2157836A1 (en)	1996-03-09	L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
Rubin	1992	Trichloroacetic acid and other non-phenol peels
EP0801945A3 (de)	2001-11-28	Verwendung von Glucosiden von Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
GB2210789A (en)	1989-06-21	Topical application for skin care
MX9806188A (es)	1998-10-31	Derivados de acidos benzofurano-acrilicos y su utilizacion como moduladores de los receptores rxrs o rars.
CA2065412C (en)	2001-05-08	Methods of preventing and reducing the size of striae distensae lesions
DE69717495D1 (de)	2003-01-09	Verwendung eines terminalia catappa extraktes
ZA957506B (en)	1996-04-18	L-carnite salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
BR0010121A (pt)	2001-12-26	Uso de compostos policìclicos aromáticos comoativadores dos receptores de tipo ppars eprocesso de tratamento cosmético
JPH07508040A (ja)	1995-09-07	セレノアミノ酸の経皮適用による外因性皮膚老化の再生
RU2683248C1 (ru)	2019-03-27	Композиция лосьона для ухода после бритья за кожей лица, имеющей угревые высыпания
DE4400714A1 (de)	1995-07-20	Mittel zur Verbesserung der Wirkung extern applizierbarer kosmetischer Präparate
BR0010120A (pt)	2001-12-26	Uso de compostos policìclicos aromáticos comoativadores dos receptores de tipo ppars em umacomposição cosmética ou farmacêutica e processode tratamento cosmético
ATE271872T1 (de)	2004-08-15	Topische carbamazepin-formulierungen und deren verwendung
Judd et al.	1993	Disseminated spiked hyperkeratosis.
WO2023081685A1 (en)	2023-05-11	Topical composition and uses thereof

Legal Events

Date	Code	Title	Description
2006-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties